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Introduction
The scourge of tuberculosis (TB) continues to have global 
dimensions as one of the world’s deadliest communicable 
diseases. In 2013, an estimated 9.0 million people developed 
TB, and 1.5 million died from the disease, 360,000 of whom 
were human immunodeficiency virus (HIV)‑positive.[1] Though 
TB is slowly declining each year, it is estimated that 37 million 
lives were saved between 2000 and 2013 through effective 
diagnosis and treatment.[1]
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Abstract
Background: The human immunodeficiency virus (HIV) pandemic has brought about a 
resurgence in tuberculosis (TB), especially in developing countries. Previous studies on TB 
lymphadenitis (TBLN) in South‑Eastern Nigeria were done before the advent of the HIV 
pandemic making a review pertinent. Aim: To evaluate the role of TBLN as a cause of 
superficial lymphadenopathy in the post‑HIV/acquired immune deficiency syndrome (AIDS) 
era of South‑Eastern Nigeria. Materials and Methods: This is a 15 years (2000–2014) 
retrospective review of all superficial lymph node biopsies (SLNBs) received at the Department 
of Morbid Anatomy, University of Nigeria Teaching Hospital, Ituku‑Ozalla Enugu, Nigeria. 
Results: One hundred and seventy‑two cases of TBLN were identified in this study constituting 
14.6% (172/1,180) of SLNBs received at our Hospital’s Morbid Anatomy Department during 
the 15 years period under review. Twenty‑eight cases of TBLN were clinically screened for 
HIV, 23 of which tested positive, representing 82.1% (23/28) of clinically screened cases. 
Acid fast bacilli demonstration was positive in 15.1% (26/172) of cases using Ziehl‑Neelsen 
stain. 48.8% (84/172) of TBLN cases were males, and 51.2% (88/172) were females with 
most (22) cases received in 2012 and least (5) cases in 2000. Most TBLN occurred in the 
21–25 years age group with a total of 21.5% (37/172) of cases and a male to female ratio 
of 1:1.5 The most common biopsy site for TBLN was the cervical group followed by the 
axillary and inguinal groups with 73.8% (127/172), 14% (24/172), and 4.7% (8/172) of cases, 
respectively. Conclusions: There is a remarkable decline in the prevalence of TB lymphadenitis 
in South‑Eastern Nigeria indicating a change in trend from the pre‑ to the post‑HIV/AIDS era 
with slightly more females now presenting with TBLN and most TB lymphadenitis patients 
now presenting with associated HIV/AIDS disease. There is an urgent need to provide modern 
diagnostic facilities in our medical laboratories.
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TB lymphadenitis (TBLN) remains the most common form of 
extrapulmonary TB with cervical lymphadenopathy being the 
most common presentation while inguinal, axillary, mesenteric, 
mediastinal, and intramammary involvement have also been 
described.[2-4] It is caused by organisms of the Mycobacterium 
tuberculosis complex[5] and is responsible for 43% of peripheral 
lymphadenopathy in the developing world.[6]
One of the earliest studies of lymphadenopathy in Nigeria 
was published by Attah[7] who in 1974 at Ibadan reported TB 
lymphadenitis as accounting for 30% of superficial lymph node 
diseases. This was followed by Onuigbo[8,9] who in 1975 at Enugu 
reported peripheral lymphadenitis as a leading manifestation of 
TB with the maximal incidence occurring in the 10–29 years 
age group and males slightly outnumbering females. This was 
subsequently followed by Ejeckam and Nwabueze[10] who in 
1984 at Enugu also reported 31.8% TBLN as the most common 
cause of superficial lymph node diseases in Enugu from January 
1973 to June 1979. Similar studies in Jos,[11] Kano,[12] Ilorin,[13] 
Benin,[14] and Calabar[15] were also in tandem with 33.05%, 30%, 
31.4%, 26.7%, and 45.9%, respectively. Abdurrahman in Zaria, 
Adedeji et al. in Benin, Oluwole et al. in Ile-Ife, Obafunwa et al. 
in Jos, and Pindiga et al. in Maiduguri have all reported TB as 
the most common single histopathological diagnosis causing 
lymphadenopathy in Nigeria.[16-20] Thus, studies in most Nigerian 
cities have reported TBLN as the most common lymph node 
pathology and cervical lymph nodes as the most frequently 
affected group of lymph nodes.[8-20] In other African cities such 
as Addis Ababa Ethiopia, Getachew et al.[21] in a study also found 
that the most common cause of lymphadenopathy (47.8%) was 
TB. They also determined that, of the lymph nodes biopsied, 
57% were cervical, 15.17% axillary, and 8.7% inguinal lymph 
nodes. Mbise[22] in a study on peripheral lymphadenopathy in 
children in Dar es Salaam, Tanzania reported that, of the 257 
excision peripheral lymph node biopsies of children between 
4 days and 15 years of age analyzed, TBLN accounted for 
67.3% while nonspecific reactive lymphadenitis, malignant 
neoplasm, and histiocytosis-X accounted for 20.6%, 11.3%, 
and 0.8%, respectively. In another study in Jimma, Ethiopia 
by Bezabih et al.[23] to determine the etiology of superficial 
enlarged lymph nodes using fine needle aspiration cytology 
they found a huge burden of benign lymph node enlargements, 
in general, and TBLN in particular. The latter was also 
responsible for about two-third of lymph node enlargements in 
South-Western parts of the country. Tiwari et al.[24] in a study 
in Nepal, South Asia, found that the most common cause of 
lymphadenopathy was TB, and the most common group of 
lymph nodes involved were the cervical lymph nodes. Moreover, 
in a clinicopathological analysis of lymphadenopathy in adults 
in Riyadh, Kingdom of Saudi Arabia, Abba et al.[25] found that 
granulomatous lymphadenopathy due to TB was the most 
frequent pattern (37.9%) and that TB was also more common 
in females than males (51% vs. 49%).
The emergence of HIV pandemic has also been associated 
with an increase in the total incidence of TB[4] and an increased 
proportion of miliary, disseminated, and extrapulmonary TB 
cases including lymphadenitis.[26] Previous studies of TBLN 
in our environment were done before the 80s[8-10] and only 
assessed data of the pre‑HIV/acquired immune deficiency 
syndrome (AIDS) era. Though these studies reported TBLN as 
the most common cause of superficial lymphadenitis, a more 
recent study to re-evaluate its prevalence is of great essence in 
view of the reported associated role of HIV/AIDS.
Materials and Methods
This was a 15 years retrospective study of 1180 superficial 
lymph nodes biopsies (SLNBs) received at the Department 
of Morbid Anatomy, University of Nigeria Teaching Hospital, 
Ituku-Ozalla Enugu, Nigeria from the year 2000 to 2014. This 
is the core referral center, offering histopathology services to 
all the five states of the South‑East region of Nigeria, as well 
as the adjoining states of the North-Central and South-South 
geopolitical regions in Nigeria. The ethical clearance for 
this study was obtained from the Health Research Ethics 
Committee of University of Nigeria Teaching Hospital and 
relevant clinical data of the patients such as histology number, 
age, sex, site of biopsy, HIV status, and other relevant clinical 
information of the patients were obtained from the duplicate 
copies of the request forms and case notes in the Pathology 
Department, as well as the hospital medical record archive. 
The tissue blocks of all 1180 SLNBs were retrieved from 
the departmental archives, and the sections made from them 
were stained with routine hematoxylin and eosin stains 
and Ziehl-Neelsen stain, a special histochemical stain for 
acid-fast bacilli (AFB). The slides were examined using a 
binocular light microscope (Leica Microsystems - Wetzlar, 
Germany), and diagnosis of TBLN was made based on the 
morphological grounds of characteristic histologic picture of 
chronic granulomatous inflammation with Langhan’s giant 
cells, and a central caseous necrosis [Figures 1 and 2] in 
addition to the presence of complementary clinical information 
Figure 1: Photomicrograph of tuberculous lymphadenitis showing 
tuberculoid granulomas with central areas of caseous necrosis [C] 
(H and E, ×40)
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on the patients. The histological demonstration of AFB by 
Ziehl-Neelsen stain [Figure 3] was observed in some biopsies 
but was not used as criteria in diagnosis because of its notoriety 
of poor sensitivity.[27] The results obtained were analyzed 
using Predictive Analytics Software Statistics for Windows, 
Version 18 (Chicago: SPSS Inc.). Tables and photomicrographs 
are used to clearly present findings.
Results
One hundred and seventy‑two cases of TBLN were identified 
in this study constituting 14.6% (172/1,180) of SLNBs received 
at our Hospital’s Morbid Anatomy Department during the 
15 years period under review. Only 28 cases of TBLN were 
clinically screened for HIV with 23 of them testing positive, 
representing 82.1% (23/28) of clinically screened cases. The 
AFB demonstration was positive in only 15.1% (26/172) of 
cases using Ziehl-Neelsen stain [Figure 3]. 48.8% (84/172) of 
TBLN cases were males, and 51.2% (88/172) were females 
giving an overall male to female ratio 1:1 with most (22) cases 
received in 2012 and the least (5) cases in 2000 [Table 1]. The 
peak number of TBLN occurred in the 21–25 years age group 
with a total of 21.5% (37/172) of cases and male to female ratio 
of 1:1.5 [Table 2]. This was followed by the 26–30 years and 31–
35 years age groups with 19.8% (34/172) and 12.2% (21/172) 
of cases, respectively. The least number of TBLN occurred in 
61–66 years and 66–70 years age groups with 0.6% (1/172) 
of cases each. The most common site of biopsy for TBLN was 
the cervical group followed by the axillary and inguinal groups 
with 73.8% (127/172), 14% (24/172), and 4.7% (8/172) of 
cases, respectively [Table 3]. The least biopsied lymph node 
was the femoral group with only 0.6% (1/172) of TBLN cases.
In adults, the highest number of TBLN was received in 
2008 with a total of 13% (19/146) of cases while the least 
was in 2000 with 2.7% (4/146) of cases. In adults, TBLN 
accounted for 146 cases, 48.6% (71/146) of cases in male, and 
51.4% (75/146) of cases in females with a male to female ratio 
of 1:1.1. The highest number of TBLN occurred in 21–25 years 
age group with a total of 25.3% (37/146) of cases. The male to 
female ratio within this age group was 1:1.5. The least number 
of TBLN occurred in 61–65 years and 66–70 years age groups 
with only one case of TBLN each. The most common site of 
lymph node biopsy in adult TBLN was the cervical group of 
lymph nodes with 73.3% (107/146) of cases followed by the 
axillary group with 13% (19/146) of cases. The least biopsied 
lymph node was the femoral group with only 0.7% (1/146) 
of cases.
In children (≤15 years), TBLN accounted for 15.1% (26/172) 
of total TBLN cases, 50% (13/26) of cases in male, and 
50% (13/26) of cases in females with a male to female ratio of 
1:1. The highest number of TBLN was received in 2007 with a 
total of 19.2% (5/26) of cases while no case of childhood TBLN 
Figure 2: Photomicrograph of tuberculous lymphadenitis showing 
tuberculoid granulomas with Langhan’s type multinucleated giant cell, 
epithelioid cells, and fibrosis at the periphery (H and E, ×400)
Figure 3: Photomicrograph of tuberculous lymphadenitis showing the 
acid‑fast bacilli of Mycobacterium tuberculosis as the short red rods in 
view (Ziehl-Neelsen, ×400)
Table 1: Annual distribution of tuberculous lymphadenitis
Year Number of SLNBs Number of TBLN Percentage of TBLN
2000 24 5 2.9
2001 58 9 5.2
2002 63 10 5.8
2003 69 9 5.2
2004 58 6 3.5
2005 80 9 5.2
2006 100 7 4.1
2007 95 15 8.7
2008 116 21 12.2
2009 98 9 5.2
2010 97 13 7.6
2011 88 13 7.6
2012 105 22 12.8
2013 89 14 8.1
2014 40 10 5.8
Total 1,180 172 100.0
SLNBs: Superficial lymph node biopsies, TBLN: Tuberculous lymphadenitis
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was recorded in 2006 and 2009. The highest number of TBLN 
occurred in 11–15 years age group with a total of 53.8% (14/26) 
of cases. The male to female ratio within this age group was 1:1. 
The least number of childhood TBLN occurred in 1–5 years 
age group with 11.5% (3/26) of cases with no case of TBLN in 
the <1 year age group. In children, the most common biopsy site 
for TBLN was the cervical group with 76.9% (20/26) of cases 
followed by axillary and inguinal groups with 19.2% (5/26) 
and 3.8% (1/26) of cases, respectively.
Discussion
TBLN continues to be a significant form of patient presentation 
at our Hospital constituting a total of 172 cases and 14.6% 
of 1180 SLNBs received at our Hospital’s Morbid Anatomy 
Department during the 15 years period under review. This 
shows a significant drop from being the most common cause 
of superficial lymphadenopathy with a 31.8% prevalence rate 
in previous studies in our environment[10] to now 14.6% which 
is the fourth, the most common becoming metastases (38.6%) 
followed by nonspecific reactive hyperplasia (21.5%), and 
lymphomas (20.1%).
TB has severally been reported as the most frequent cause 
of lymphadenopathy[8-20] and the most common form of 
extrapulmonary TB,[2,4,28] but the trend appears to be changing 
as Anunobi et al.[29] in a similar study in Lagos reported chronic 
nonspecific lymphadenitis (34%) as the most common cause of 
lymph node enlargement followed by metastatic lymph node 
lesions (33.6%), TB (17.4%), and lymphomas (14.2%). In our 
study, TBLN is now slightly more common in females than 
males (51.2% vs. 48.8%) and also peaks in the 21–25 years 
age group with a total of 37 (21.5%) cases. This; however, 
remains consistent with a similar study in Ethiopia[21] which 
also a reported mean age of 24.2 years and also with previous 
studies done three decades ago in our environment[9,10] which 
also reported a maximal incidence in the 10–29 years age 
group but then with males slightly outnumbering females. 
However, a study of lymphadenopathy in adults in Riyadh, 
Kingdom of Saudi Arabia, by Abba et al.[25] reported that TB 
was more common in females than males (51% vs. 49%). This 
is consistent with our finding that TBLN is now slightly more 
common in females than males (51.2% vs. 48.8%) [Table 2]. 
The most common biopsy site for TBLN in our study was the 
cervical group of superficial lymph nodes with 127 (73.8%) 
cases followed by the axillary group with 24 (14%). This is 
also in agreement with previous studies in Enugu,[9,10] other 
Nigerian cities,[11-20] and the world.[21-25]
In adults, TBLN accounted for 146 cases of lymphadenopathy 
and was more common in the younger age group, peaking at 
the 21–25 years age group with an overall male to female ratio 
of 1:1.1. This is largely in agreement with previous reports in 
our environment[9,10] and other Nigerian cities,[14,30] affecting the 
youths in their prime age, though now slightly affecting more 
females. The least cases of TBLN occurred in late middle age 
and the elderly with 61–65 years and 66–70 years age groups 
having only one case of TBLN each.
In children (≤15 years), TBLN accounted for 26 (15.1%) cases 
with 13 (50%) cases in male and 13 (50%) cases in females 
with a male to female ratio of 1:1. The highest number of 
TBLN occurred in 11–15 years age group with a total of 
14 (53.8%) cases. The male to female ratio within this age 
group was 1:1. The least number of childhood TBLN occurred 
in 1–5 years age group with three (11.5%) cases with no case 
of TBLN in the <1 year age group. The absence of TBLN in 
the <1 year age group may be due to protection offered by 
transferred maternal immunity from maternal breast milk 
while the increase in the number of TBLN cases with increase 
in age from >1 year groups could be due to decrease in the 
acquired maternal immunity, as well as increased exposure to 
other TB predisposing factors such as co-infection with HIV, 
malnutrition, and young age.[31] The biopsy sites for TBLN in 
adults and children were consistent with those of the general 
population.
However, in a study to determine the diseases that commonly 
presented with lymphadenopathy in Port of Spain, Trinidad, 
and Raju[32] analyzed 651 diagnostic lymph node biopsies and 
found that nonspecific reactive hyperplasia was common, and 
Table 2: Age and sex distribution of tuberculous 
lymphadenitis
Age group (years) Female Male Total Percentage
1-5 2 1 3 1.7
6-10 4 5 9 5.2
11-15 7 7 14 8.1
16-20 6 11 17 9.9
21-25 22 15 37 21.5
26-30 20 14 34 19.8
31-35 10 11 21 12.2
36-40 4 7 11 6.4
41-45 2 1 3 1.7
46-50 6 3 9 5.2
51-55 2 5 7 4.1
56-60 3 2 5 2.9
61-65 0 1 1 0.6
66-70 0 1 1 0.6
Total 88 84 172 100.0
Percentage 51.2 48.8 100
Table 3: Biopsy sites of tuberculous lymphadenitis
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TBLN was rare. This result is discordant with our findings, those 
of other Nigerian cities [9-20] and other developing countries.[21-25] 
The predominance of TB in Nigeria, predilection of cervical 
lymph node and female sex in superficial lymphadenopathy in 
most Nigerian cities, is in agreement with our studies and those 
from the rest of the African continent. TB remains a serious 
though preventable cause of superficial lymphadenopathy in 
many parts of Africa.[33]
There is nevertheless a resurgence of TB, especially in 
developing countries[34] and much of it is thought to be 
related to HIV infection[3,35] with reports of increasing TB 
lymphadenopathy in association with HIV positivity.[36,37] The 
higher rate of TBLN in some African countries like Zambia 
and Malawi is reported to be due to higher HIV infection 
rates.[36,38] The effect of HIV infection in increasing the 
incidence of TBLN was observed in our study as 23 of the 
28 cases of TBLN screened for HIV were positive giving a 
HIV positivity of 82.1% within the screened TBLN population. 
Thus, though the incidence of TBLN appears to be declining in 
our environment, HIV/AIDS endemicity remains a significant 
factor. It is pertinent that since TBLN is the most common 
presentation of extrapulmonary TB, and TB is an HIV/
AIDS‑defining illness, all suspected TBLN patients should 
be evaluated for HIV infection.
The diagnosis of TBLN in this study was made based on a 
histologic picture of chronic granulomatous inflammation 
with Langhan’s giant cells and central caseous necrosis, and 
the presence of complementary clinical information on the 
patients. This diagnostic modality is usually sufficient but in 
some cases, granulomas lack caseation or are poorly formed 
posing a diagnostic challenge. Some cases of granuloma 
lacking caseation or other specific features were seen but were 
excluded in this review. It is possible that some of these were 
early TB lesions yet to develop caseous necrosis though they 
were negative for AFB. Histological demonstration of AFB by 
Ziehl-Neelsen stain in TB is the goal standard for a diagnosis of 
TB, but it is notorious for its poor sensitivity,[27,37-40] especially 
in extrapulmonary TB owing to the paucibacillary nature of 
the specimen,[27] as well as the effect of formalin and xylene on 
the stainability of mycobacteria by Ziehl-Neelsen method.[39,40] 
In our study, AFB demonstration using Ziehl-Neelsen stain 
yielded only 15% positivity. This underlies the need for more 
sensitive techniques such as fluorescence auramine staining, 
immunofluorescence, and nucleic acid hybridization as 
necessary diagnostic tools for a more accurate diagnosis of 
TB lymphadenitis.[12,27,41] An integrated approach of combining 
low-cost polymerase chain reaction together with classic 
microbiological assays and histopathology can significantly 
improve diagnostic accuracy; enabling early treatment, 
improved quality of life HIV patients, reduction of hospital 
stays, relapses, and drug resistance.[42] These facilities are 
presently not available in most health centers in the developing 
world, where the scourge of TB is prevalent. So much is 
globally spent annually in the control of TB, but little is 
utilized in providing diagnostic facilities. This highlights the 
need to provide modern diagnostic facilities in our medical 
laboratories.
Conclusion
There is a remarkable decline in the prevalence of TB 
lymphadenitis in South-Eastern Nigeria indicating a change 
in trend from the pre- to the post-HIV/AIDS era with 
slightly more females now presenting with TBLN and most 
TB lymphadenitis patients now presenting with associated 
HIV/AIDS disease. There is an urgent need to provide modern 
diagnostic facilities in our medical laboratories.
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